Post Categories
Novel Coronavirus Testing: Part III
May 6, 2020
Antigen Testing Part I of this series on testing for the novel coronavirus covered the real-time reverse transcription polymerase chain reaction (rRT-PCR) assay, which…
Airborne Coronavirus Discovered in China – Could It Transmit the Novel Coronavirus?
May 6, 2020
Earlier this week, we discussed an aerosolized droplet study conducted by the University of Pennsylvania Perelman School of Medicine and the National Institutes of…
Aerosolized Droplet Study
April 29, 2020
Can the Novel Coronavirus Spread Through Speaking? There are conflicting opinions on whether the novel coronavirus, the virus that causes COVID-19, can be spread…
Novel Coronavirus Testing: Part II
April 27, 2020
Serology Testing “Test, test, test,” was the singular message from the World Health Organization’s Director-General Tedros Adhanom Ghebreyesus during remarks on the coronavirus pandemic…
Novel Coronavirus Testing: Part I
April 20, 2020
Real-Time Reverse Transcriptase Polymerase Chain Reaction Testing is the crucial first step to identifying and treating COVID-19. In the past few months, uncertainty has…
Clinical Trials: Coronavirus Impact and FDA Guidelines
April 13, 2020
The spread of the coronavirus is affecting every facet of the pharmaceutical industry — including clinical trials that are currently underway or scheduled for…
Selecting a CRO for Chronic Disease Drug Development Using Small Molecules
April 1, 2020
Though not as buzzworthy as biologics or some other trendy therapies, small molecules (i.e., organic compounds with a low molecular weight) make up the…
Beauty and the Bacteria: Mechanical Forces in a Multispecies Biofilm Colony
March 30, 2020
Diverse, abundant microbial communities are found across all of the earth’s ecosystems, from the human intestinal tract to deep water hydrothermal vents to rainforest…
Solanezumab Study Misses the Mark for the Fourth Time
March 17, 2020
Last month, American pharmaceutical company Eli Lilly ended its fourth study investigating the effectiveness of solanezumab, a potential drug therapy for people with mild cognitive…
CAR-T and CRISPR Cancer Trial Shows Promise
March 2, 2020
There is new hope for future innovation in the fast-moving field of cancer immunotherapy. Earlier this month, researchers from the University of Pennsylvania and…
Gene Therapy Innovation Strongly Encouraged by FDA with New Guidances
February 10, 2020
On January 28, 2020, the United States Food and Drug Administration (FDA) announced the release of six final guidances on gene therapy manufacturing and the…
The Value of a Startup Incubator
January 20, 2020
Building a successful company from scratch will always be difficult, but it helps to begin the journey in an affordable, welcoming space that provides…
Experimental mRNA Vaccine Takes a Multivalent Approach to the Flu
February 6, 2023
The events of the COVID-19 pandemic have largely upended how we perceive and respond to global viral threats. One positive change is the technology…
Discovery: Pupal Ants Produce Milk for Their Colonies
February 1, 2023
Pupating ants produce milk — and scientists have only just noticed. Research published in Nature in November describes researchers observing for the first time…
The Resurgence of Strep A and the Effects of the COVID-19 Pandemic
January 30, 2023
An unexpected increase in cases of streptococcal A (strep A) infection in the United Kingdom is troubling for families, healthcare practitioners, and researchers. Although…
Pigs Could Solve the Organ Transplant Crisis
January 25, 2023
2022 held a number of significant breakthroughs in researchers’ ongoing efforts to solve the organ transplant crisis. Many of those breakthroughs were in xenotransplantation,…
The Unlikely Role of Hops in the Prevention of Alzheimer’s Disease
January 23, 2023
A team of Italian scientists from the University of Milan-Bicocca have recently discovered a possible use of hops, the flowers used to enhance both…
Costly, Life-Changing Type 1 Diabetes Drug Delays Disease, Receives FDA Approval
January 16, 2023
The U.S. Food and Drug Administration has approved teplizumab-mzw (TZIELD™), a drug developed by New Jersey-based Provention Bio to delay the onset of type…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
